Advertisement

Transoral Robotic Surgery

  • Robert Kang
  • Thomas Gernon
  • Ellie Maghami
Chapter

Abstract

Transoral robotic surgery (TORS) refers to surgery that is performed on the upper aerodigestive tract through the mouth, assisted by robotic instruments. The arms of the robot can reach previously inaccessible areas of the pharynx and larynx through the mouth, allowing for a minimally invasive approach through the natural oral cavity orifice. Prior to the advent of robotic technology, open techniques requiring mandible splitting often were necessary to surgically access cancers in these anatomic areas, and radiation with or without chemotherapy was often relied upon to treat these tumors, in order to avoid this morbid type of approach. Therefore, TORS has enabled the head and neck surgeon to surgically remove tumors that not only were difficult to access but also were often treated nonsurgically.

Keywords

Transoral robotic surgery (TORS) Oropharyngeal cancer HPV 

References

  1. 1.
    Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin. 2016;66:7–30.CrossRefGoogle Scholar
  2. 2.
    Chaturvedi AK, Engels EA, Anderson WF, Gillison ML. Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States. J Clin Oncol. 2008;26:612–9.CrossRefPubMedCentralGoogle Scholar
  3. 3.
    Chaturvedi AK, Engels EA, Pfeiffer RM, Hernandez BY, Xiao W, Kim E, et al. Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol. 2011;29:4294–301.CrossRefPubMedCentralGoogle Scholar
  4. 4.
    Gillison ML, Koch WM, Capone RB, Spafford M, Westra WH, Wu L, et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst. 2000;92:709–20.CrossRefPubMedCentralGoogle Scholar
  5. 5.
    Gillison ML, D'Souza G, Westra W, Sugar E, Xiao W, Begum S, Viscidi R. Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers. J Natl Cancer Inst. 2008;100:407–20.CrossRefPubMedCentralGoogle Scholar
  6. 6.
    Dayyani F, Etzel CJ, Liu M, Ho CH, Lippman SM, Tsao AS. Meta-analysis of the impact of human papillomavirus (HPV) on cancer risk and overall survival in head and neck squamous cell carcinomas (HNSCC). Head Neck Oncol. 2010;2:15.CrossRefPubMedCentralGoogle Scholar
  7. 7.
    Fakhry C, Westra WH, Li S, Cmelak A, Ridge JA, Pinto H, et al. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst. 2008;100:261–9.CrossRefPubMedCentralGoogle Scholar
  8. 8.
    Weinstein GS, Quon H, Newman HJ, Chalian JA, Malloy K, Lin A, et al. Transoral robotic surgery alone for oropharyngeal cancer: an analysis of local control. Arch Otolaryngol Head Neck Surg. 2012;138:628–34.CrossRefPubMedCentralGoogle Scholar
  9. 9.
    Weinstein GS, O'Malley BW Jr, Cohen MA, Quon H. Transoral robotic surgery for advanced oropharyngeal carcinoma. Arch Otolaryngol Head Neck Surg. 2010;136:1079–85.CrossRefPubMedCentralGoogle Scholar
  10. 10.
    Cohen MA, Weinstein GS, O'Malley BW Jr, Feldman M, Quon H. Transoral robotic surgery and human papillomavirus status: oncologic results. Head Neck. 2011;33:573–80.CrossRefPubMedCentralGoogle Scholar
  11. 11.
    de Almeida JR, Li R, Magnuson JS, Smith RV, Moore E, Lawson G, et al. Oncologic outcomes after transoral robotic surgery: a multi-institutional study. JAMA Otolaryngol Head Neck Surg. 2015;141:1043–51.CrossRefPubMedCentralGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Division of Otolaryngology/Head & Neck Surgery, Department of SurgeryCity of HopeDuarteUSA

Personalised recommendations